ArticleJAMA network open2022

Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.

Avital Klein-Brill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.